These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 1388202)
1. Secretion of vitamin A and retinol-binding protein into plasma is depressed in rats by N-(4-hydroxyphenyl)retinamide (fenretinide). Smith JE; Lawless DC; Green MH; Moon RC J Nutr; 1992 Oct; 122(10):1999-2009. PubMed ID: 1388202 [TBL] [Abstract][Full Text] [Related]
2. N-(4-hydroxyphenyl)retinamide (fenretinide) induces retinol-binding protein secretion from liver and accumulation in the kidneys in rats. Schaffer EM; Ritter SJ; Smith JE J Nutr; 1993 Sep; 123(9):1497-503. PubMed ID: 8360775 [TBL] [Abstract][Full Text] [Related]
3. Retinol-binding protein secretion from the liver of N-(4-hydroxyphenyl) retinamide-treated rats. Ritter SJ; Smith JE Biochim Biophys Acta; 1996 Jun; 1290(2):157-64. PubMed ID: 8645719 [TBL] [Abstract][Full Text] [Related]
4. Secretion of N-(4-hydroxyphenyl) retinamide-retinol-binding protein from liver parenchymal cells: evidence for reduced affinity of the complex for transthyretin. Holven KB; Natarajan V; Gundersen TE; Moskaug JO; Norum KR; Blomhoff R Int J Cancer; 1997 May; 71(4):654-9. PubMed ID: 9178822 [TBL] [Abstract][Full Text] [Related]
5. Effects of N-(4-hydroxyphenyl)retinamide on vitamin A metabolism in rats. Adams WR; Smith JE; Green MH Proc Soc Exp Biol Med; 1995 Feb; 208(2):178-85. PubMed ID: 7831350 [TBL] [Abstract][Full Text] [Related]
6. Alteration of retinol-binding-protein concentrations by the synthetic retinoid fenretinide in healthy human subjects. Dimitrov NV; Meyer CJ; Perloff M; Ruppenthal MM; Phillipich MJ; Gilliland D; Malone W; Minn FL Am J Clin Nutr; 1990 Jun; 51(6):1082-7. PubMed ID: 2140925 [TBL] [Abstract][Full Text] [Related]
7. In vitro interaction of fenretinide with plasma retinol-binding protein and its functional consequences. Berni R; Formelli F FEBS Lett; 1992 Aug; 308(1):43-5. PubMed ID: 1386578 [TBL] [Abstract][Full Text] [Related]
8. Effects of N-(4-hydroxyphenyl)retinamide supplementation on vitamin A metabolism. Lewis KC; Zech LA; Phang JM Cancer Res; 1994 Aug; 54(15):4112-7. PubMed ID: 8033144 [TBL] [Abstract][Full Text] [Related]
9. Plasma retinol level reduction by the synthetic retinoid fenretinide: a one year follow-up study of breast cancer patients. Formelli F; Carsana R; Costa A; Buranelli F; Campa T; Dossena G; Magni A; Pizzichetta M Cancer Res; 1989 Nov; 49(21):6149-52. PubMed ID: 2529028 [TBL] [Abstract][Full Text] [Related]
10. N-(4-hydroxyphenyl)-retinamide increases lecithin:retinol acyltransferase activity in rat liver. Matsuura T; Zhao Z; Ross AC J Nutr; 1996 Oct; 126(10):2474-80. PubMed ID: 8857507 [TBL] [Abstract][Full Text] [Related]
11. Effects of acute inflammation on plasma retinol, retinol-binding protein, and its mRNA in the liver and kidneys of vitamin A-sufficient rats. Rosales FJ; Ritter SJ; Zolfaghari R; Smith JE; Ross AC J Lipid Res; 1996 May; 37(5):962-71. PubMed ID: 8725149 [TBL] [Abstract][Full Text] [Related]
12. Biotransformation and protein binding of N-(4-hydroxyphenyl)retinamide in murine mammary epithelial cells. Bunk MJ; Kinahan JJ; Sarkar NH Cancer Lett; 1985 Apr; 26(3):319-26. PubMed ID: 2986832 [TBL] [Abstract][Full Text] [Related]
13. Retinoid metabolism in the prostate: effects of administration of the synthetic retinoid N-(4-hydroxyphenyl)retinamide. Lewis KC; Hochadel JF Cancer Res; 1999 Dec; 59(23):5947-55. PubMed ID: 10606240 [TBL] [Abstract][Full Text] [Related]
14. Effects of chronic administration of N-(4-hydroxyphenyl)retinamide (4-HPR) in rats on vitamin A metabolism in the eye. Lewis KC; Zech LA; Phang JM Eur J Cancer; 1996 Sep; 32A(10):1803-8. PubMed ID: 8983293 [TBL] [Abstract][Full Text] [Related]
15. Effect of N-(4-hydroxyphenyl) retinamide on food intake, growth, and mammary gland development in rats. Radcliffe JD; Moon RC Proc Soc Exp Biol Med; 1983 Nov; 174(2):270-5. PubMed ID: 6227008 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of N-(4-hydroxyphenyl)-all-trans-retinamide in rats. Swanson BN; Zaharevitz DW; Sporn MB Drug Metab Dispos; 1980; 8(3):168-72. PubMed ID: 6104581 [TBL] [Abstract][Full Text] [Related]
17. Identification of the fenretinide metabolite 4-oxo-fenretinide present in human plasma and formed in human ovarian carcinoma cells through induction of cytochrome P450 26A1. Villani MG; Appierto V; Cavadini E; Valsecchi M; Sonnino S; Curley RW; Formelli F Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6265-75. PubMed ID: 15448016 [TBL] [Abstract][Full Text] [Related]
18. Retinoids: in vitro interaction with retinol-binding protein and influence on plasma retinol. Berni R; Clerici M; Malpeli G; Cleris L; Formelli F FASEB J; 1993 Sep; 7(12):1179-84. PubMed ID: 8375617 [TBL] [Abstract][Full Text] [Related]
19. The interaction of N-ethyl retinamide with plasma retinol-binding protein (RBP) and the crystal structure of the retinoid-RBP complex at 1.9-A resolution. Zanotti G; Malpeli G; Berni R J Biol Chem; 1993 Nov; 268(33):24873-9. PubMed ID: 8227049 [TBL] [Abstract][Full Text] [Related]
20. The complex between retinol and retinol-binding protein is formed in the rough microsomes of liver following repletion of vitamin A-depleted rats. Smith JE; DeMoor LM; Handler CE; Green EL; Ritter SJ Biochim Biophys Acta; 1998 Mar; 1380(1):10-20. PubMed ID: 9545517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]